Cargando…

The performance of sequence symmetry analysis as a tool for post-market surveillance of newly marketed medicines: a simulation study

BACKGROUND: Sequence symmetry analysis (SSA) is a potential tool for rapid detection of adverse drug events (ADRs) associated with newly marketed medicines utilizing computerized claims data. SSA is robust to patient specific confounders but it is sensitive to the underlying utilization trends in th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pratt, Nicole L, Ilomäki, Jenni, Raymond, Chris, Roughead, Elizabeth E
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4035856/ https://www.ncbi.nlm.nih.gov/pubmed/24886247 http://dx.doi.org/10.1186/1471-2288-14-66

Ejemplares similares

Usefulness of medicine screening tools in the frame of pharmaceutical post-marketing surveillance
por: Waffo Tchounga, Christelle Ange, et al.
Publicado: (2023)

Sequence symmetry analysis graphic adjustment for prescribing trends
por: Preiss, Adrian Kym, et al.
Publicado: (2019)

Regulatory withdrawal of medicines marketed with uncertain benefits: the bevacizumab case study
por: Vitry, Agnes, et al.
Publicado: (2015)

Post-marketing surveillance of anti-malarial medicines used in Malawi
por: Chikowe, Ibrahim, et al.
Publicado: (2015)

Post marketing surveillance of selected veterinary medicines in Tanzania mainland
por: Fimbo, Adam M., et al.
Publicado: (2022)

Financial Symmetry and Moods in the Market
por: Savona, Roberto, et al.
Publicado: (2015)

Medicine-Induced Acute Kidney Injury Findings from Spontaneous Reporting Systems, Sequence Symmetry Analysis and a Case–Control Study with a Focus on Medicines Used in Primary Care
por: Roughead, Elizabeth E., et al.
Publicado: (2022)

Japanese Physicians’ Views on Drug Post-Marketing Surveillance
por: Maeda, Kazuki, et al.
Publicado: (2015)

Post-marketing safety surveillance of the rotavirus vaccine in India
por: Kang, Gagandeep, et al.
Publicado: (2023)

National post-market surveillance assessment of veterinary medicines in Korea during the past decade
por: Kang, JeongWoo, et al.
Publicado: (2017)

Post-marketing safety surveillance and re-evaluation of Xueshuantong injection
por: Li, Chunxiao, et al.
Publicado: (2018)

Sapropterin for phenylketonuria: A Japanese post‐marketing surveillance study
por: Tamura, Mina, et al.
Publicado: (2022)

Simulating complex patient populations with hierarchical learning effects to support methods development for post-market surveillance
por: Davis, Sharon E., et al.
Publicado: (2023)

Safety of measles-containing vaccines in post-marketing surveillance in Anhui, China
por: Meng, Fan-Ya, et al.
Publicado: (2017)

Ontology-based specification and generation of search queries for post-market surveillance
por: Uciteli, Alexandr, et al.
Publicado: (2019)

Post-Marketing Safety Surveillance for the Adjuvanted Recombinant Zoster Vaccine: Methodology
por: Tavares-Da-Silva, Fernanda, et al.
Publicado: (2020)

Analyzing the U.S. Post-marketing safety surveillance of COVID-19 vaccines
por: Albalawi, Omar M., et al.
Publicado: (2022)

An Overview of COVID-19 Vaccine Safety and Post-marketing Surveillance Systems
por: Younus, Manal Mohammed, et al.
Publicado: (2021)

Worldwide post‐marketing safety surveillance experience with tofacitinib in ulcerative colitis
por: Rubin, David T., et al.
Publicado: (2021)

Drug-induced Neuropsychiatric Adverse Events Using Post-Marketing Surveillance
por: Wakabayashi, Tomohito, et al.
Publicado: (2022)

Beat the market: win with proven stock selection and market timing tools
por: Appel, Gerald
Publicado: (2009)

The marketer's visual tool kit
por: Richey, Terry
Publicado: (1994)

Safety and Efficacy of Zonisamide in Patients with Epilepsy: A Post-Marketing Surveillance Study
por: Lee, Hye Jin, et al.
Publicado: (2015)

Safety analysis of Epzicom® (lamivudine/abacavir sulfate) in post-marketing surveillance in Japan†
por: Kurita, Tomoko, et al.
Publicado: (2014)

Insulin Glulisine in Pregnancy – Experience from Clinical Trials and Post-marketing Surveillance
por: Doder, Zoran, et al.
Publicado: (2015)

Post-Marketing Surveillance of a generic Oxaliplatin (Alvoxal(Ⓡ)) in Iranian Patients with Cancer
por: Shahi, Farhad, et al.
Publicado: (2021)

Efficacy, Safety, and Durability of Brolucizumab: An 8-Month Post-Marketing Surveillance Analysis
por: Saba, Nicholas J, et al.
Publicado: (2023)

Analysis of the Korean generic medicine market: Factors affecting the market share of generic medicines
por: Kim, Dong‐Sook, et al.
Publicado: (2021)

Do newly marketed generic medicines expand markets using descriptive time series analysis and mixed logit models? Korea as an exemplar and its implications
por: Kwon, Hye-Young, et al.
Publicado: (2016)

Use of a Healthcare Claims Database for Post-Marketing Safety Assessments of Eribulin in Japan: A Comparative Assessment with a Prospective Post-Marketing Surveillance Study
por: Sakata, Yukinori, et al.
Publicado: (2019)

Marketing of medicines in primary care: An analysis of direct marketing mailings and advertisements
por: Dankers, Marloes, et al.
Publicado: (2023)

Mastering the stock market: high probability market timing & stock selection tools
por: Person, John L
Publicado: (2013)

The market for medicine. Essay review.
por: Loudon, I
Publicado: (1995)

Access to Medicines, Access to Markets
por: Sismondo, Sergio
Publicado: (2020)

Fragmentation in trader preferences among multiple markets: market coexistence versus single market dominance
por: Nicole, Robin, et al.
Publicado: (2021)

Erratum to: Do newly marketed generic medicines expand markets using descriptive time series analysis and mixed logit models? Korea as an exemplar and its implications
por: Kwon, Hye-Young, et al.
Publicado: (2017)

Marketing global marketing /
por: Kotabe, Masaaki
Publicado: (2001)

A Japanese Post-marketing Surveillance of Cetuximab (Erbitux(®)) in Patients with Metastatic Colorectal Cancer
por: Ishiguro, Megumi, et al.
Publicado: (2012)

Post-Marketing Surveillance of Levofloxacin 0.5% Ophthalmic Solution for External Ocular Infections
por: Kanda, Yoshiko, et al.
Publicado: (2012)

Safety and Effectiveness of Natalizumab: First Report of Interim Results of Post-Marketing Surveillance in Japan
por: Saida, Takahiko, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_nqtjbs0s1nhoolnlvkav8qbid2